Retour sur lavenir.net
   ARGENX SE 785.400 € (+0,13 %)     MELEXIS 76.550 € (+0,20 %)     AB INBEV 73.520 € (-1,55 %)     CMB.TECH 12.440 € (-0,48 %)     WHAT'S COOKING GP 146.000 € (+1,04 %)     KBC ANCORA 81.100 € (+0,25 %)     KBC 117.700 € (+0,38 %)     LOTUS BAKERIES 11 520.000 € (0,00 %)     ONTEX GROUP 2.510 € (-0,59 %)     FAGRON 23.850 € (+0,21 %)     SYENSQO 64.550 € (-3,37 %)     ELIA GROUP 139.400 € (+0,65 %)     ABO GROUP 3.760 € (-2,08 %)     CARE PROPERTY INV. 12.540 € (-0,48 %)     WDP 22.080 € (-1,95 %)     TESSENDERLO 19.360 € (-2,12 %)     GBL 79.450 € (+0,63 %)     SHURGARD 25.750 € (0,00 %)     VASTNED 29.700 € (-0,17 %)     TITAN S.A. 51.200 € (-2,48 %)     SOLVAY 26.480 € (-1,34 %)     ASCENCIO 52.300 € (-0,38 %)     AEDIFICA 71.750 € (-0,21 %)     AGFA-GEVAERT 0.425 € (+0,47 %)     RECTICEL 10.900 € (+1,49 %)     ENERGYVISION 13.940 € (-2,11 %)     TUBIZE-FIN 230.200 € (+2,13 %)     ONWARD MEDICAL 2.570 € (-2,65 %)     OXURION 0.003 € (+7,14 %)     AGEAS 69.050 € (-1,00 %)     BREDERODE 104.600 € (0,00 %)     GIMV 45.900 € (+1,66 %)     CENERGY 23.180 € (-0,52 %)     IBA 16.920 € (+0,95 %)     UMICORE 20.440 € (-1,83 %)     NYRSTAR 0.060 € (-12,79 %)     BIOTALYS 3.110 € (-0,32 %)     KINEPOLIS GROUP 36.350 € (-0,41 %)     ORANGE BELGIUM 21.500 € (0,00 %)     NYXOAH 1.488 € (-2,75 %)     COLRUYT 35.720 € (-0,45 %)     RETAIL ESTATES 70.200 € (+0,14 %)     DEME GROUP 174.800 € (-0,79 %)     SIPEF 93.000 € (+0,11 %)     SOFINA 221.800 € (+0,73 %)     VIOHALCO 18.920 € (-2,07 %)     CIE BOIS SAUVAGE 304.000 € (+0,66 %)     DECEUNINCK 2.190 € (-1,35 %)     HOME INVEST BE. 19.400 € (+0,52 %)     VAN DE VELDE 30.200 € (0,00 %)     BANQUP GROUP 2.350 € (+11,90 %)     ECONOCOM GROUP 1.480 € (-2,31 %)     FLUXYS BELGIUM D 19.300 € (-1,03 %)     MONTEA 65.900 € (-1,93 %)     D'IETEREN GROUP 169.400 € (-0,65 %)     COFINIMMO 84.400 € (-0,12 %)     UCB 263.500 € (+1,93 %)     ACKERMANS V.HAAREN 282.000 € (-0,98 %)     PROXIMUS 5.965 € (-1,97 %)     VGP 84.000 € (-0,36 %)  
   DANONE 72.040 € (-0,11 %)     ARCADIS 33.040 € (-0,24 %)     ASML HOLDING 1 612.000 € (+2,14 %)     DSM FIRMENICH AG 81.620 € (+2,05 %)     BIOMERIEUX 69.850 € (-1,96 %)     KERING 265.650 € (-0,52 %)     2CRSI 30.960 € (+12,50 %)     ERAMET 46.260 € (+2,44 %)     ADVICENNE 1.330 € (+24,30 %)     THALES 220.500 € (+1,85 %)     EXAIL TECHNOLOGIES 121.000 € (+3,68 %)     SAFRAN 336.500 € (+1,14 %)     GTT 184.400 € (+0,55 %)     SCOR SE 31.560 € (-1,31 %)     BOLLORE 4.100 € (0,00 %)     AHOLD DEL 35.330 € (-0,28 %)     SANOFI 75.500 € (+0,57 %)     PROSUS 38.385 € (+2,43 %)     L'OREAL 387.050 € (-0,24 %)     SAINT GOBAIN 77.540 € (-3,80 %)     AIRBUS 191.580 € (-0,17 %)     AIR LIQUIDE 172.720 € (-0,08 %)     ING GROEP N.V. 27.240 € (+0,13 %)     TOTALENERGIES 68.980 € (+0,91 %)     SCHNEIDER ELECTRIC 278.100 € (+0,74 %)     AXA 43.390 € (-0,05 %)     PEUGEOT INVEST 55.200 € (-2,30 %)     CAFOM 14.400 € (-0,69 %)     ARCELORMITTAL SA 51.500 € (-1,94 %)     TIKEHAU CAPITAL 16.560 € (+0,98 %)     Coca-ColaEuropacif 88.900 € (+0,57 %)     EQUASENS 34.950 € (-0,71 %)     LEBON 94.200 € (+0,21 %)     ABIONYX PHARMA 2.050 € (+0,49 %)     DONTNOD 0.419 € (0,00 %)     FERMENTALG 0.520 € (+8,90 %)     BROADPEAK 2.380 € (+4,39 %)     ALSTOM 15.005 € (-2,44 %)     STEF 117.000 € (-0,17 %)     SOITEC 114.300 € (-0,04 %)     ESSILORLUXOTTICA 163.500 € (-3,05 %)     BASTIDE LE CONFORT 24.950 € (+0,40 %)     AMG 32.220 € (-2,07 %)     MAUNA KEA TECH 0.171 € (+9,04 %)     CSG 12.970 € (+2,27 %)     ADP 114.500 € (-1,04 %)     SOLUTIONS 30 SE 0.601 € (-1,64 %)     ENGIE 27.400 € (+0,33 %)     HERMES INTL 1 615.500 € (-0,65 %)     RENAULT 25.280 € (-3,03 %)     LACROIX GROUP 18.250 € (+1,39 %)     STMICROELECTRONICS 63.580 € (+1,60 %)     INPOST 15.380 € (-0,19 %)     METAVISIO 0.001 € (0,00 %)     SERGEFERRARI GROUP 7.800 € (-2,50 %)     SERGEFERRARI GROUP 7.800 € (-2,50 %)     CARREFOUR 16.415 € (+0,18 %)     TRIODOS BANK 26.500 € (-1,12 %)     VIRIDIEN 84.900 € (-0,12 %)     JCDECAUX 19.390 € (+1,78 %)  
News Réglementées
29/06/2026 20:00

IGEL Appoints James Millington as Field CTO for Healthcare in EMEA

EQS-News: IGEL / Key word(s): Personnel
IGEL Appoints James Millington as Field CTO for Healthcare in EMEA

29.06.2026 / 20:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


The move strengthens IGEL's healthcare leadership in EMEA and expands support for customers and partners across the region.

LONDON, June 29, 2026 /PRNewswire/ -- IGEL, a global software company delivering the Adaptive Secure Endpoint Platform™ for modern digital workspaces and secure access, today announced the expansion of its CTO bench with the appointment of James Millington as Field CTO for Healthcare, EMEA. The appointment reflects IGEL's continued investment in healthcare and other strategic growth areas.

IGEL Appoints James Millington as Field CTO for Healthcare in EMEA

As Field CTO, Healthcare EMEA, Millington will work closely with healthcare customers, field teams, and partners across the region to drive adoption of IGEL's immutable endpoint platform in clinical and care delivery environments. His appointment complements the work of Jason Mafera, who leads IGEL's healthcare Field CTO efforts in North America, giving IGEL dedicated healthcare Field CTO leadership on both sides of the Atlantic.

Millington brings extensive experience working with healthcare providers globally, including leadership roles at Armis, VMware, Imprivata, and Citrix. He takes on the Field CTO role after nearly three years leading Product Marketing at IGEL, where he helped shape the company's market positioning and platform narrative alongside CEO Klaus Oestermann. He now brings that strategic and healthcare-focused experience directly to customers and partners across the EMEA market.

"Healthcare organizations across EMEA are increasingly seeking modern, resilient, and secure endpoint strategies that enable better patient care while reducing operational risk. James brings the healthcare expertise, strategic insight, and customer focus needed to help organizations navigate this transformation. His appointment reinforces IGEL's commitment to the healthcare sector and our mission to deliver a more secure and resilient digital healthcare experience through our Adaptive Secure Endpoint Platform, preventative security approach, and business continuity and disaster recovery capabilities. We are excited to have James leading this effort as we deepen our investment in healthcare and help organizations across EMEA build secure, resilient, and future-ready digital workspaces," said Matthias Haas, Managing Director & CTO, IGEL.

The announcement reflects IGEL's continued focus on healthcare as a strategic vertical. Through the IGEL Adaptive Secure Endpoint Platform™, IGEL helps healthcare organizations support secure, reliable clinician access while simplifying endpoint management and improving resilience across distributed care environments.

"Healthcare is entering a defining period of innovation across EMEA. Providers must find new ways to lower operational costs, improve care quality, support digital and virtual care models, and bring services closer to patients — all while defending clinical environments against an increasingly complex cybersecurity threat landscape. IGEL has a unique role to play in that transformation. With IGEL, healthcare organizations can establish an immutable, secure-by-design endpoint foundation that helps protect access to critical systems, strengthen resilience, and reduce complexity at scale. I'm excited to help customers and partners across EMEA apply that approach to the realities of modern care delivery," said James Millington, Field CTO, Healthcare EMEA, IGEL.

In his new role, Millington will focus on deepening IGEL's partner ecosystem across EMEA and helping healthcare organizations align IGEL within broader secure access and resilience strategies.

About IGEL

IGEL is a global software company delivering the Adaptive Secure Endpoint Platform™ for modern digital workspaces and secure access. Through its secure endpoint OS, Universal Management Suite (UMS), and IGEL App Portal, IGEL enables a Preventative Security Model™ that helps organizations strengthen security, improve resilience, and centrally govern endpoint access across distributed environments.

The platform delivers the IGEL Adaptive Secure Desktop™, providing secure, reliable access to SaaS, DaaS, VDI, and enterprise applications across distributed environments. Backed by more than 130 validated technology partners, IGEL extends Zero Trust and SASE frameworks to the endpoint. Founded in 2001, IGEL is headquartered in Germany and has operations in the United States. Learn more at www.igel.com

IGEL logo

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/igel-appoints-james-millington-as-field-cto-for-healthcare-in-emea-302813539.html

rt.gif?NewsItemId=EN94319&Transmission_Id=202606291353PR_NEWS_EURO_ND__EN94319&DateId=20260629


29.06.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2356332  29.06.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière